• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有宫颈受累的子宫内膜腺癌的复发模式及并发症

Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement.

作者信息

Boente M P, Orandi Y A, Yordan E L, Miller A, Graham J E, Kirshner C, Wilbanks G D

机构信息

Department of Surgery, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

出版信息

Ann Surg Oncol. 1995 Mar;2(2):138-44. doi: 10.1007/BF02303629.

DOI:10.1007/BF02303629
PMID:7728567
Abstract

BACKGROUND

Cervical involvement in endometrial carcinoma is a diverse entity, and the optimal management of these patients is not well understood.

METHODS

Recurrence patterns and complications in 202 patients with histologically confirmed endometrial carcinoma with cervical involvement were retrospectively studied.

RESULTS

The 5-year actuarial survival rate for all patients was 65%. Recurrences were documented in 80 (40%) of the patients, and the overall long-term survival rate in this group was 4%. Patients treated with radical hysterectomy (n = 33) had a 6% isolated pelvic recurrence rate and the lowest serious complication rate among the five treatment groups despite having the highest frequency of risk factors for recurrence among any of the groups studied. Patients treated with extrafascial hysterectomy alone (n = 37) had a 14% pelvic recurrence rate and very few complications. When radiotherapy preceded extrafascial hysterectomy (n = 37), the frequency of pelvic recurrences was 30%, and 19% experienced serious gastrointestinal or genitourinary tract complications. When radiotherapy followed extrafascial hysterectomy (n = 68), the pelvic recurrence rate was 24%, and 13% experienced serious complications. Overall, 24% of patients (49 of 202) had isolated pelvic recurrences, whereas 10% (21 of 202) had isolated distant recurrences and 5% (10 of 202) were simultaneously diagnosed with both pelvic and distant recurrences.

CONCLUSIONS

This large data base suggests that older conventional forms of therapy, particularly those using preoperative radiotherapy, subject the patient to significant morbidity over a 5- to 10-year period and, in terms of local control, are not necessarily superior to therapeutic modalities using primary surgical evaluation, such as radical hysterectomy. Consideration of primary surgery should be given in the appropriate situation, and radical hysterectomy should be considered when gross cervical involvement is encountered and intraoperative exploration does not show obvious extrauterine disease.

摘要

背景

子宫内膜癌累及宫颈是一种复杂的情况,目前对这类患者的最佳治疗方案尚不清楚。

方法

对202例经组织学确诊为子宫内膜癌累及宫颈的患者的复发模式和并发症进行回顾性研究。

结果

所有患者的5年精算生存率为65%。80例(40%)患者出现复发,该组的总体长期生存率为4%。接受根治性子宫切除术的患者(n = 33)孤立盆腔复发率为6%,在五个治疗组中严重并发症发生率最低,尽管在所有研究组中其复发风险因素出现频率最高。仅接受筋膜外子宫切除术的患者(n = 37)盆腔复发率为14%,并发症很少。在筋膜外子宫切除术前行放射治疗的患者(n = 37),盆腔复发频率为30%,19%出现严重的胃肠道或泌尿生殖道并发症。在筋膜外子宫切除术后行放射治疗的患者(n = 68),盆腔复发率为24%,13%出现严重并发症。总体而言,24%的患者(202例中的49例)有孤立盆腔复发,而10%(202例中的21例)有孤立远处复发,5%(202例中的10例)同时被诊断为盆腔和远处复发。

结论

这个大型数据库表明,传统的较老治疗方式,特别是那些使用术前放疗的方式,会使患者在5至10年期间出现明显的发病率,并且就局部控制而言,不一定优于使用初次手术评估的治疗方式,如根治性子宫切除术。在适当情况下应考虑初次手术,当遇到宫颈明显受累且术中探查未发现明显子宫外疾病时,应考虑根治性子宫切除术。

相似文献

1
Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement.伴有宫颈受累的子宫内膜腺癌的复发模式及并发症
Ann Surg Oncol. 1995 Mar;2(2):138-44. doi: 10.1007/BF02303629.
2
Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.广泛性/根治性子宫切除术及盆腔淋巴结清扫术在伴有宫颈受累的子宫内膜癌中的作用。
Gynecol Oncol. 2001 Oct;83(1):72-80. doi: 10.1006/gyno.2001.6346.
3
Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.332例低危I期子宫内膜腺癌患者接受子宫切除术及阴道近距离放疗,未进行正式分期淋巴结采样,长期生存率良好且无阴道复发:一项前瞻性试验报告
Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):373-80. doi: 10.1016/s0360-3016(97)00040-0.
4
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.与传统放疗相比,调强放疗治疗宫颈癌根治术后盆腔局部复发的回顾性研究
Int J Gynecol Cancer. 2015 Jul;25(6):1058-65. doi: 10.1097/IGC.0000000000000360.
5
Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study.宫旁受侵的子宫内膜癌新辅助放疗及近距离放疗:一项 CHIRENDO 研究组的研究。
Int J Gynecol Cancer. 2021 Jan;31(1):78-84. doi: 10.1136/ijgc-2020-001797. Epub 2020 Oct 30.
6
Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.宫颈癌根治术及盆腔淋巴结清扫术后伴腹膜后淋巴结转移的同步调制加速放疗
Int J Gynecol Cancer. 2015 Jun;25(5):903-9. doi: 10.1097/IGC.0000000000000426.
7
Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer.局部复发性子宫内膜癌患者的预后因素及治疗结果
Cancer. 1994 Aug 15;74(4):1303-8. doi: 10.1002/1097-0142(19940815)74:4<1303::aid-cncr2820740420>3.0.co;2-g.
8
Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.子宫内膜I-IV期透明细胞癌的治疗结果及失败模式:对辅助放疗的意义
Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1272-6. doi: 10.1016/s0360-3016(02)04404-8.
9
Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.宫颈癌根治性子宫切除术后盆腔复发的放射治疗
Gynecol Oncol. 1998 Aug;70(2):241-6. doi: 10.1006/gyno.1998.5093.
10
Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?II期子宫内膜癌的辅助放疗:单纯近距离放疗对局部控制是否足够?
Brachytherapy. 2015 Jul-Aug;14(4):427-32. doi: 10.1016/j.brachy.2015.02.196. Epub 2015 Apr 22.

引用本文的文献

1
OS and DFS are affected by different diagnostic methods and hysterectomy procedures in endometrial cancer patients: A single-center retrospective study.子宫内膜癌患者的总生存期(OS)和无病生存期(DFS)受不同诊断方法和子宫切除术的影响:一项单中心回顾性研究。
Cancer Med. 2023 Sep;12(18):19072-19080. doi: 10.1002/cam4.6465. Epub 2023 Aug 16.
2
Cancer of the endometrium: current aspects of diagnostics and treatment.子宫内膜癌:诊断与治疗的当前进展
World J Surg Oncol. 2004 Jul 21;2:24. doi: 10.1186/1477-7819-2-24.

本文引用的文献

1
Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement.伴有宫颈受累的子宫内膜腺癌的预后因素及长期生存情况
Gynecol Oncol. 1993 Dec;51(3):316-22. doi: 10.1006/gyno.1993.1297.
2
Risk factors and prognosis in stage II endometrial cancer.
Gynecol Oncol. 1982 Aug;14(1):49-61. doi: 10.1016/0090-8258(82)90050-6.
3
Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment.伴有宫颈受累的子宫内膜癌(II期):预后因素及放射 - 手术联合治疗的价值
Gynecol Oncol. 1982 Feb;13(1):76-86. doi: 10.1016/0090-8258(82)90011-7.
4
Residual carcinoma in the surgical specimen of patients with endometrial adenocarcinoma undergoing preoperative radiation therapy. A study of 80 patients and a literature review.
Gynecol Oncol. 1984 Jun;18(2):165-76. doi: 10.1016/0090-8258(84)90024-6.
5
Stage II cancer of the endometrium: a pathologic and clinical study.
Gynecol Oncol. 1984 May;18(1):1-17. doi: 10.1016/0090-8258(84)90001-5.
6
Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approach.
Cancer. 1988 Apr 15;61(8):1528-34. doi: 10.1002/1097-0142(19880415)61:8<1528::aid-cncr2820610808>3.0.co;2-9.
7
Management of stage II endometrial adenocarcinoma.
Obstet Gynecol. 1988 Mar;71(3 Pt 1):323-6.
8
AIDS.
Int J Gynaecol Obstet. 1989 Feb;28(2):190-2.
9
Management of endometrial cancer with suspected cervical involvement.
Obstet Gynecol. 1990 Jun;75(6):1016-22.
10
Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
Gynecol Oncol. 1990 Dec;39(3):368-73. doi: 10.1016/0090-8258(90)90268-p.